jlagasse

Author's posts

Emergent technologies are allowing consumers greater control and access to care

The shift happening in healthcare is similar to trends in personal wealth management, with beneficiaries assuming greater control.

Consumer satisfaction lower for hospitals, higher for payers

Outpatient care settings are garnering more satisfaction than other providers, but overall satisfaction is down.

Profits drive rising prices for MS drugs, say industry executives

The researchers determined that the current rebate system, which incentivizes high list prices for drugs, plays a central role driving up costs for consumers.

Pennsylvania partners with GetInsured to build and operate state-based health insurance exchange

Chief among the partnership’s goals is higher quality service and better affordability for people in the state purchasing insurance on the exchange.

High out-of-pocket costs can make medications out of reach for millions of Americans with cardiovascular disease

Non-compliance has several causes, but recent years have seen patients assuming a greater share of healthcare costs, likely fanning the flame.

More than half of Americans have avoided medical care due to cost

Prices are a priority, with 91% saying that costs for medical services should be as readily available as prices on a restaurant menu.

Benefit design, higher deductibles will increase bad debt for hospitals

Legislative proposals could reduce bad debt, but would likely introduce additional complexity to billing processes.

Majority of parents say socioeconomic factors negatively impact their families’ health

Most parents believe they have the resources to raise healthy children, but significant hurdles can pose a persistent challenge.

Premiums, deductibles eating up more of employees’ incomes, finds Commonwealth Fund

In 18 states, the average health plan deductible is now 5% or more of income, meeting the threshold for underinsurance.

Patients treated outside NCI centers less likely to receive high-cost lung cancer drugs

Patients treated at NCI-designated cancer centers were 10% more likely to be given these drugs than were patients treated in other settings.